In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Nikolaos Scarmeas Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Nikolaos
Last Name:Scarmeas
Title:MD
Affiliation:COLUMBIA UNIVERSITY
Department:NEUROLOGY
Street Address 1:622 W 168th street
Street Address 2:PH 19th floor
City:New York
State/Province:NY
Zip/Postal Code:10032
Country/Territory:U.S.A.
Phone:212-3421350
Fax:212-3421838
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 6 June 2003]
View all comments by Nikolaos Scarmeas
Clinical Interests:
Alzheimer Disease, Aging Process
Research Focus:
Diagnosis, Brain imaging, Bioinformatics/Statistics, Clinical trials, Epidemiology
Work Sector(s):
University
Top Papers
1. Mayer S., Commichau C., Scarmeas N., Presciutti M., Bates J., Copeland D.: Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients.
Neurology 2001; 56: 292-298

2. Scarmeas N., Eidelberg D., Frucht SJ.: Oculogyric-like crises in a 92-year-old woman with vascular parkinsonism.
Movement Disorders 2001; 16; 2: 353-355.

3. Scarmeas N., Chin S. S., Marder K.: Neurodegenerative Disease Case Studies: Cortical Basal Ganglionic Degeneration.
Science’s SAGE KE 2001; http://sageke.sciencemag.org.

4. Scarmeas N., Levy G., Tang M., Manly J., Stern Y.: Influence of leisure activity on the incidence of Alzheimer’s disease.
Neurology 2001; 57: 2236-2242.

5. Scarmeas N., Brandt J., Albert M., Devanand D., Marder K., Bell K., Ciappa A., Tycko B., Stern Y.: Association between APOE genotype and psychiatric symptoms in Alzheimer’s disease (AD).
Neurology 2002; 58:1182-1188.

6. Scarmeas N., Shih T., Ottman R., Stern Y., Rowland LP.: Premorbid weight, body mass index, and athletics in amyatrophic lateral sclerosis and related syndromes.
Neurology 2002; 59: 773-775.

7. Scarmeas N., Zarahn E., Anderson K., Habeck C., Hilton J., Flynn J., Marder K., Bell K., Sackeim H., Van Heertum R., Moeller J., Stern Y.: Association of life activities with cerebral blood flow in Alzheimer’s disease: Implications for the cognitive reserve hypothesis.
Archives of Neurology 2002; 60: 359-365.

8. Commihau C., Scarmeas N., Mayer S.: Risk factors for fever in the neurologic intensive care unit. Neurology 2003; 60: 837-841.

9. Scarmeas N., Zarahn E., Anderson K.E., Hilton J., Flynn J., Van Heertum R., Sackeim H., Stern Y. Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage 2002; In press.

10. Scarmeas N., Stern Y.: Cognitive reserve and lifestyle. Journal of Clinical and Experimental Neuropsychology 2002; In press.

11. Scarmeas N., Rowland LP.: Amyotrophic Lateral Sclerosis and Sport. Neurology 2003; In press.

12. Scarmeas N., Habeck C., Anderson K., Stern Y.: APOE genotype and Cerebral Blood Flow in healthy young subjects. JAMA 2003; In press.



What is the greatest void to date in our knowledge of Alzheimer's Disease?
Diagnostic biomarker
Treatment

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad